Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Health Behaviour Change

Roche Basel Switzerland

Roche’s Ocrevus is first primary progressive MS drug in EU

Analysts predict the drug could be a $3bn product by 2021

- PMLiVE

FDA panel rejects Aradigm/Grifols’ inhaled antibiotic

Further evidence is required to warrant approval according to the US regulator

- PMLiVE

Ferring agrees Chinese reproductive medicine research deal

Work with the Chinese Academy of Sciences on the long-term project

- PMLiVE

Healthcare Communications agency F/NE joins GLOBALHealthPR’s network

The South-African agency has a presence in over 40 other countries

- PMLiVE

Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

She succeeds Bruno Strigini who retires

Four ways technology will make your exhibition stand more successful

Apex Events and Exhibitions

Transforming access in rare diseases

A quiet revolution is underway that could transform access to medicines in rare diseases, according to Duchenne UK, the charity at the heart of a new project to streamline evidence-gathering...

AstraZeneca AZ

AZ gets EMA green light for severe asthma drug Fasenra

The biologic respiratory treatment will go up against GSK’s Nucala and Teva’s Cinqaero

Digital pharma marketing: 5 ways to avoid localisation problems

Localisation of digital materials isn’t difficult but it can go wrong. Here’s how to keep everything on track.

Anthill Agency

- PMLiVE

Vertex’s Orkambi receives EU green light for licence extension

Becomes first medicine to treat the underlying cause of CF in children

Roche and GE Healthcare plan ‘industry first’ digital platform

Co-developed clinical decision support software will begin with cancer and critical care

- PMLiVE

Celebrating a magical year at the Lucid Winter Meeting

In the frosty sunlight of a winter morning, employees from across the Lucid Group gathered to celebrate a magical year of success at the Lucid Annual Winter Meeting. Traditionally being...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links